Iannuzzi M.C. Fontana J.R.

Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.

JAMA. 2011; 305: 391-399View in Article Scopus (257) PubMed Crossref Google ScholarBirnie D.H. Nery P.B. Ha A.C. et al.

Cardiac sarcoidosis.

J Am Coll Cardiol. 2016; 68: 411-421View in Article Scopus (269) PubMed Crossref Google ScholarIwai K. Tachibana T. Takemura T. et al.

Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan.

Acta Pathol Jpn. 1993; 43: 372-376View in Article PubMed Google ScholarPerry A. Vuitch F.

Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.

Arch Pathol Lab Med. 1995; 119: 167-172View in Article PubMed Google ScholarHamzeh N. Steckman D.A. Sauer W.H. et al.

Pathophysiology and clinical management of cardiac sarcoidosis.

Nat Rev Cardiol. 2015; 12: 278-288View in Article Scopus (67) PubMed Crossref Google ScholarGilotra N.A. Griffin J.M. Pavlovic N. et al.

Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review.

J Card Fail. 2022; 28: 113-132View in Article Scopus (10) Abstract Full Text Full Text PDF Google ScholarChareonthaitawee P. Beanlands R.S. Chen W. et al.

Joint SNMMI-ASNC expert consensus document on the role of.

J Nucl Cardiol. 2017; 24: 1741-1758View in Article Scopus (0) PubMed Crossref Google ScholarFutamatsu H. Suzuki J. Adachi S. et al.

Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia.

Int J Cardiovasc Imaging. 2006; 22: 443-448View in Article Scopus (0) PubMed Crossref Google ScholarMomose M. Kadoya M. Koshikawa M. et al.

Usefulness of 67Ga SPECT and integrated low-dose CT scanning (SPECT/CT) in the diagnosis of cardiac sarcoidosis.

Ann Nucl Med. 2007; 21: 545-551View in Article Scopus (17) Crossref Google ScholarNakazawa A. Ikeda K. Ito Y. et al.

Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis.

Chest. 2004; 126: 1372-1376View in Article Scopus (52) PubMed Abstract Full Text Full Text PDF Google ScholarTellier P. Valeyre D. Nitenberg A. et al.

Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole.

Eur J Nucl Med. 1985; 11: 201-204View in Article Scopus (0) PubMed Crossref Google ScholarTellier P. Paycha F. Antony I. et al.

Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis.

Am J Med. 1988; 85: 189-193View in Article PubMed Abstract Full Text PDF Google ScholarChristopoulos G. Jouni H. Acharya G.A. et al.

Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol.

J Nucl Cardiol. 2019; 119: 167-172View in Article Google ScholarDilsizian V. Bacharach S.L. Beanlands R.S. et al.

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.

J Nucl Cardiol. 2016; 23: 1187-1226View in Article Scopus (315) PubMed Crossref Google ScholarTahara N. Tahara A. Nitta Y. et al.

Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.

JACC Cardiovasc Imaging. 2010; 3: 1219-1228View in Article Scopus (128) PubMed Crossref Google ScholarMiller R.J.H. Cadet S. Pournazari P. et al.

Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis.

J Nucl Cardiol. 2022; 29: 86-96View in Article Scopus (11) Crossref Google ScholarTerasaki F. Yoshinaga K.

New guidelines for diagnosis of cardiac sarcoidosis in Japan.

Annals of Nuclear Cardiology. 2017; 3: 42-45View in Article Crossref Google ScholarBirnie D.H. Sauer W.H. Bogun F. et al.

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Heart Rhythm. 2014; 11: 1305-1323View in Article PubMed Abstract Full Text Full Text PDF Google ScholarVita T. Okada D.R. Veillet-Chowdhury M. et al.

Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis.

Circ Cardiovasc Imaging. 2018; 11: e007030View in Article PubMed Crossref Google ScholarDivakaran S. Stewart G.C. Lakdawala N.K. et al.

Diagnostic accuracy of advanced imaging in cardiac sarcoidosis.

Circ Cardiovasc Imaging. 2019; 12: e008975View in Article Scopus (35) PubMed Crossref Google ScholarPatel V.N. Pieper J.A. Poitrasson-Rivière A. et al.

The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.

J Nucl Cardiol. 2021; https://doi.org/10.1007/s12350-021-02780-xView in Article Scopus (2) Crossref Google ScholarDivakaran S. Blankstein R.

FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis.

J Nucl Cardiol. 2021; https://doi.org/10.1007/s12350-021-02809-1View in Article Scopus (1) Crossref Google ScholarBlankstein R. Osborne M. Naya M. et al.

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

J Am Coll Cardiol. 2014; 63: 329-336View in Article Scopus (440) PubMed Crossref Google ScholarWicks E.C. Menezes L.J. Barnes A. et al.

Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.

Eur Heart J Cardiovasc Imaging. 2018; 19: 757-767View in Article Scopus (88) PubMed Crossref Google ScholarSperry B.W. Tamarappoo B.K. Oldan J.D. et al.

Prognostic impact of extent, severity, and heterogeneity of abnormalities on.

JACC Cardiovasc Imaging. 2018; 11: 336-345View in Article Scopus (65) Crossref Google ScholarGiblin G.T. Murphy L. Stewart G.C. et al.

Cardiac sarcoidosis: when and how to treat inflammation.

Card Fail Rev. 2021; 7: e17View in Article Scopus (4) Crossref Google ScholarWand A.L. Chrispin J. Saad E. et al.

Current state and future directions of multimodality imaging in cardiac sarcoidosis.

Front Cardiovasc Med. 2021; 8: 785279View in Article Crossref Google ScholarOsborne M.T. Hulten E.A. Singh A. et al.

Reduction in 1⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

J Nucl Cardiol. 2014; 21: 166-174View in Article Scopus (185) PubMed Crossref Google ScholarMuser D. Santangeli P. Castro S.A. et al.

Prognostic role of serial quantitative evaluation of.

Eur J Nucl Med Mol Imaging. 2018; 45: 1394-1404View in Article Scopus (0) PubMed Crossref Google ScholarSaric P. Young K.A. Rodriguez-Porcel M. et al.

PET imaging in cardiac sarcoidosis: a narrative review with Focus on novel PET tracers.

Pharmaceuticals. 2021; 14https://doi.org/10.3390/ph14121286View in Article Scopus (8) Crossref Google ScholarNing N. Guo H.H. Iagaru A. et al.

Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis.

J Card Fail. 2019; 25: 307-311View in Article Scopus (23) PubMed Abstract Full Text Full Text PDF Google ScholarOkada D.R. Saad E. Wand A.L. et al.

Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.

JACC Cardiovasc Imaging. 2020; 13: 1280-1282View in Article Scopus (8) Crossref Google ScholarSubramanian M. Swapna N. Ali A.Z. et al.

Pre-treatment myocardial.

JACC Cardiovasc Imaging. 2021; 14: 2008-2016View in Article Scopus (0) PubMed Crossref Google Scholarten Bokum A.M. Hofland L.J. de Jong G. et al.

Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas.

Eur J Clin Invest. 1999; 29: 630-636View in Article Scopus (71)